Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NCRSC advances

Mononuclear Mg(ii) and Ca(ii) metallocarboxylates of N-phthaloyl-γ-aminobutyric acid: synthesis, characterization, ds-DNA binding, preliminary anticancer evaluation against MDA-MB-231 cells, and computational studies.

4 affiliations
  1. 1Department of Chemistry, School of Natural Sciences (SNS), National University of Sciences and Technology (NUST) Islamabad 44000 Pakistan [email protected] [email protected].
  2. 2Pakistan Science Foundation 1-Constitution Avenue G-5/2 Islamabad 44000 Pakistan.
  3. 3Department of Physics & Astronomy, School of Natural Sciences (SNS), National University of Sciences and Technology (NUST) Islamabad 44000 Pakistan.
  4. 4Department of Biochemistry, College of Science, King Saud University P.O. Box 2455 Riyadh 11451 Saudi Arabia.

Abstract

This study reports the synthesis of neurotransmitter-inspired, biolabile mononuclear Mg(ii)/(NY1) and Ca(ii)/(NY2) metallocarboxylates of N-phthaloyl-γ-aminobutyric acid ligand (NPGABA), motivated by the growing relevance of metallocarboxylates in addressing essential metal-ion deficiencies. Extensive spectral (i.e. IR, UV-vis, ¹H-NMR, ¹³C-NMR, AAS, and ICP-AES) and analytical (SEM, micro-analysis and thermal gravimetric analysis) techniques were used to characterize and confirm the formation of the ligand and its metal carboxylate complexes. The complexes were confirmed to have the formulas [Mg(NPGABA)₂(H₂O)₂]₄ (NY1) and [Mg(NPGABA)₂(H₂O)₄] (NY2), where NPGABA is the abbreviation of the ligand in its deprotonated form. The DNA-binding interactions of the NPGABA ligand (NY0) and its alkaline earth metal carboxylate complexes with magnesium (Mg/NY1) and calcium (Ca/NY2) were investigated through a combination of biophysical, computational, and biological assays. UV-visible absorption studies revealed a significant hyperchromic effect without a bathochromic/hypsochromic shift, indicative of a non-intercalative external binding mode (i.e., minor groove binding or electrostatic interaction with the anionic sugar phosphate backbone of DNA). Binding constants (K b) were calculated by UV-vis spectroscopy at a temperature of 310.15 K and pH of 7.4 as 2.18 × 10⁵ M⁻¹ (NY0), 4.05 × 10⁵ M⁻¹ (NY1), and 4.21 × 10⁵ M⁻¹ (NY2), with Gibbs free energies (ΔG°) of -31.68, -33.28, and -33.38 kJ mol⁻¹, respectively, confirming spontaneous interactions. Similarly, fluorescence emission spectroscopic studies demonstrated eminent quenching without any shift, providing complementary evidence for the presence of external non-intercalative interactions. Accordingly, the binding constants (K b) calculated by this technique under the same physiological conditions were 1.2 × 10⁴ M⁻¹ (NY0), 4.41 × 10⁴ M⁻¹ (NY1), and 8.61 × 10⁴ M⁻¹ (NY2), with binding site numbers of 0.86 (NY0), 0.95 (NY1), and 1.01 (NY2) and Gibbs free energies (ΔG°) of -24.23, -27.56, and -29.27 kJ mol⁻¹, respectively, confirming the spontaneity of the interaction process. Molecular docking simulations against the canonical B-DNA (PDB: 1BNA) and the aromatase cytochrome P450 enzyme (PDB: 3EQM) also supported the occurrence of non-intercalative external binding interactions, with NY2 demonstrating the most favorable binding pose and energy. This non-intercalative external binding interaction was further endorsed by minute perturbation in the DNA solution viscosity and analogical consistency with classical groove binders like netropsin and distamycin A (K b ≈ 10⁵-10⁷ M⁻¹). The observed DNA binding affinity trend (NY2 > NY1 > NY0) has a direct correlation with the cytotoxic potency of the investigated compounds against triple negative breast cancer cells (MDA-MB-231). This consolidated investigation proved NY2 as a non-intercalative DNA-binding small molecule with preliminary anticancer activity, offering a strategic route for developing sustainable metallocarboxylate-based therapeutics.

Related

  1. Phytochemical characterization and preliminary antimicrobial evaluation of a mono- and sesquiterpene-rich essential oil of Salvia limbata C.A.Mey.
    Mansureh Ghavam, Ines Castangia, Matteo Perra +2
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. Immune–metabolic heterogeneity and prognostic associations in breast cancer: development of an eight-gene risk model and preliminary functional characterization of NAT2
    Yuchen Li, Shaochao Zhan, Ting Li +4
    Scientific ReportsPeer-reviewedCC BY 4.0Full textOncologyCrossref
  3. Proteomic and lipidomic characterization of Hemipyrellia ligurriens larval extracts using LC-MS/MS and GC-MS: Identification of putative antimicrobial molecules and preliminary functional assessment
    Pluemkamon Phuwanatsarunya, Sophit Khanthawong, Worasak Kaewkong +8
    PLOS OnePeer-reviewedCC BY 4.0Full textProteomics & metabolomicsMicrobiologyPLOS
  4. Analytical Characterization, Pharmacokinetics, Safety, and Preliminary Immunogenicity of GNR-062, an Agalsidase Beta Biosimilar Candidate, in Healthy Male Volunteers.
    Ivan Lyagoskin, Maksim Smolov, Oksana Markova +6
    Biotech (Basel (Switzerland))Peer-reviewedCC BYFull textPhysiologyEurope PMC
  5. Preliminary functional characterization of the LMNA c.929 A > G (p.Gln310Arg) variant identified in a patient with dilated cardiomyopathy.
    Zikang Han, Yonghao Sheng, Han Sun +6
    HereditasPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
BibTeX
@article{abbas2026mononuclear,
  title = {{Mononuclear Mg(ii) and Ca(ii) metallocarboxylates of N-phthaloyl-γ-aminobutyric acid: synthesis, characterization, ds-DNA binding, preliminary anticancer evaluation against MDA-MB-231 cells, and computational studies.}},
  author = {Naeem Abbas and Muhammad Arfan and Yasir Iqbal and Mudassir Iqbal and Naeem Ahmed and Mona G Alharbi and Mansour K Gatasheh},
  journal = {RSC advances},
  year = {2026},
  month = oct,
  doi = {10.1039/d6ra07684j},
  url = {https://europepmc.org/article/MED/42899204},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Mononuclear Mg(ii) and Ca(ii) metallocarboxylates of N-phthaloyl-γ-aminobutyric acid: synthesis, characterization, ds-DNA binding, preliminary anticancer evaluation against MDA-MB-231 cells, and computational studies.
AU  - Naeem Abbas
AU  - Muhammad Arfan
AU  - Yasir Iqbal
AU  - Mudassir Iqbal
AU  - Naeem Ahmed
AU  - Mona G Alharbi
AU  - Mansour K Gatasheh
PY  - 2026
DA  - 2026/10/19
JO  - RSC advances
DO  - 10.1039/d6ra07684j
UR  - https://europepmc.org/article/MED/42899204
AB  - This study reports the synthesis of neurotransmitter-inspired, biolabile mononuclear Mg(ii)/(NY1) and Ca(ii)/(NY2) metallocarboxylates of N-phthaloyl-γ-aminobutyric acid ligand (NPGABA), motivated by the growing relevance of metallocarboxylates in addressing essential metal-ion deficiencies. Extensive spectral (i.e. IR, UV-vis, ¹H-NMR, ¹³C-NMR, AAS, and ICP-AES) and analytical (SEM, micro-analysis and thermal gravimetric analysis) techniques were used to characterize and confirm the formation of the ligand and its metal carboxylate complexes. The complexes were confirmed to have the formulas [Mg(NPGABA)₂(H₂O)₂]₄ (NY1) and [Mg(NPGABA)₂(H₂O)₄] (NY2), where NPGABA is the abbreviation of the ligand in its deprotonated form. The DNA-binding interactions of the NPGABA ligand (NY0) and its alkaline earth metal carboxylate complexes with magnesium (Mg/NY1) and calcium (Ca/NY2) were investigated through a combination of biophysical, computational, and biological assays. UV-visible absorption studies revealed a significant hyperchromic effect without a bathochromic/hypsochromic shift, indicative of a non-intercalative external binding mode (i.e., minor groove binding or electrostatic interaction with the anionic sugar phosphate backbone of DNA). Binding constants (K b) were calculated by UV-vis spectroscopy at a temperature of 310.15 K and pH of 7.4 as 2.18 × 10⁵ M⁻¹ (NY0), 4.05 × 10⁵ M⁻¹ (NY1), and 4.21 × 10⁵ M⁻¹ (NY2), with Gibbs free energies (ΔG°) of -31.68, -33.28, and -33.38 kJ mol⁻¹, respectively, confirming spontaneous interactions. Similarly, fluorescence emission spectroscopic studies demonstrated eminent quenching without any shift, providing complementary evidence for the presence of external non-intercalative interactions. Accordingly, the binding constants (K b) calculated by this technique under the same physiological conditions were 1.2 × 10⁴ M⁻¹ (NY0), 4.41 × 10⁴ M⁻¹ (NY1), and 8.61 × 10⁴ M⁻¹ (NY2), with binding site numbers of 0.86 (NY0), 0.95 (NY1), and 1.01 (NY2) and Gibbs free energies (ΔG°) of -24.23, -27.56, and -29.27 kJ mol⁻¹, respectively, confirming the spontaneity of the interaction process. Molecular docking simulations against the canonical B-DNA (PDB: 1BNA) and the aromatase cytochrome P450 enzyme (PDB: 3EQM) also supported the occurrence of non-intercalative external binding interactions, with NY2 demonstrating the most favorable binding pose and energy. This non-intercalative external binding interaction was further endorsed by minute perturbation in the DNA solution viscosity and analogical consistency with classical groove binders like netropsin and distamycin A (K b ≈ 10⁵-10⁷ M⁻¹). The observed DNA binding affinity trend (NY2 > NY1 > NY0) has a direct correlation with the cytotoxic potency of the investigated compounds against triple negative breast cancer cells (MDA-MB-231). This consolidated investigation proved NY2 as a non-intercalative DNA-binding small molecule with preliminary anticancer activity, offering a strategic route for developing sustainable metallocarboxylate-based therapeutics.
SN  - 2046-2069
ER  -